Overview
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Eligibility
Inclusion Criteria:
- Willingness to provide written informed consent
- Age 18 to 40
- Weight 55 to 95 kg
- Body mass index (BMI) 18 to 30 kg/m2
- Healthy men
Exclusion Criteria:
- History of hypersensitivity to monoclonal antibodies or study drug
- Participation in any other investigational drug study
- History of cancer
- Recent acute illness
- Positive test for HIV, hepatitis B/C
- History of substance abuse or nicotine use
- Recent blood donation
- History of pituitary disorder
- Any condition that prevents the participant from complying with study procedures